| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |